LakeShore Biopharma Co., Ltd. (NASDAQ:LSB – Get Free Report) shares dropped 33% on Wednesday . The stock traded as low as $0.57 and last traded at $0.53. Approximately 819,833 shares were traded during mid-day trading, an increase of 880% from the average daily volume of 83,626 shares. The stock had previously closed at $0.79.
LakeShore Biopharma Stock Down 33.0%
The company has a debt-to-equity ratio of 0.05, a current ratio of 1.02 and a quick ratio of 0.75. The firm’s 50-day simple moving average is $0.73 and its two-hundred day simple moving average is $1.10.
About LakeShore Biopharma
LakeShore Biopharma Co, Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People’s Republic of China and Other Countries or Regions.
Featured Articles
- Five stocks we like better than LakeShore Biopharma
- Retail Stocks Investing, Explained
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- Stock Dividend Cuts Happen Are You Ready?
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- What is a Low P/E Ratio and What Does it Tell Investors?
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Receive News & Ratings for LakeShore Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LakeShore Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
